Stockscreener 앱 받기
17.19
2.20%
0.37
시간 외 거래:
16.35
-0.84
-4.89%
전일 마감가:
$16.82
열려 있는:
$16.58
하루 거래량:
978.31K
Relative Volume:
1.21
시가총액:
$1.56B
수익:
-
순이익/손실:
$-249.31M
주가수익비율:
-5.1934
EPS:
-3.31
순현금흐름:
$-209.70M
1주 성능:
-0.92%
1개월 성능:
+4.75%
6개월 성능:
-26.76%
1년 성능:
-18.06%
1일 변동 폭
$16.12
$17.22
1주일 범위
$16.12
$17.42
52주 변동 폭
$15.97
$32.52
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
명칭
Rocket Pharmaceuticals Inc
전화
646-440-9100
주소
350 FIFTH AVENUE, NEW YORK, NY
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-02-01 | 개시 | Morgan Stanley | Overweight |
| 2022-11-08 | 개시 | Canaccord Genuity | Buy |
| 2022-11-01 | 개시 | BTIG Research | Buy |
| 2022-07-08 | 개시 | Raymond James | Outperform |
| 2021-10-20 | 재개 | Cowen | Outperform |
| 2021-03-02 | 개시 | Stifel | Buy |
| 2021-02-18 | 개시 | Needham | Buy |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-12-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-07-02 | 개시 | JP Morgan | Overweight |
| 2020-06-25 | 재개 | BofA/Merrill | Buy |
| 2020-06-01 | 재개 | Oppenheimer | Outperform |
| 2019-11-06 | 개시 | Chardan Capital Markets | Buy |
| 2019-09-26 | 개시 | Piper Jaffray | Overweight |
| 2019-04-23 | 개시 | Robert W. Baird | Outperform |
| 2019-03-15 | 개시 | BofA/Merrill | Buy |
| 2019-02-05 | 개시 | Oppenheimer | Outperform |
| 2018-09-13 | 개시 | Ladenburg Thalmann | Buy |
| 2018-07-10 | 개시 | William Blair | Outperform |
모두보기
Rocket Pharmaceuticals Inc 주식(RCKT)의 최신 뉴스
Harbor Capital Advisors Inc. Has $3.11 Million Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals executive sells $51,205 in common stock - Investing.com
Rocket Pharmaceuticals executive sells $51,205 in common stock By Investing.com - Investing.com UK
Long Term Trading Analysis for (RCKT) - Stock Traders Daily
(RCKT) Trading Report - Stock Traders Daily
Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ - GlobeNewswire
Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - India Shorts
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 5.3%Here's What Happened - MarketBeat
Fanconi Anemia Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies | Foresee Pharma, Rocket Pharma, John Diaz, Novartis, Sierra Oncology - The Globe and Mail
Scotiabank Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Sector Outperform Recommendation - MSN
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap UpWhat's Next? - MarketBeat
Investors in cash trouble should check out Rocket Pharmaceuticals Inc (RCKT) - SETE News
Rocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by Analysts at Scotiabank - MarketBeat
The Attractiveness of Investing In Rocket Pharmaceuticals Inc (RCKT) is Growing - Knox Daily
Rocket Pharmaceuticals Inc (RCKT)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Recent Insider Activity Could Benefit Pacific Biosciences of California Inc (PACB) - Knox Daily
Verisk Analytics Inc [VRSK] Investment Appeal on the Rise - Knox Daily
Rocket Pharmaceuticals Inc (RCKT)’s stock chart: A technical perspective - US Post News
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $52.00 Consensus Target Price from Brokerages - MarketBeat
Trading (RCKT) With Integrated Risk Controls - Stock Traders Daily
Rocket Pharmaceuticals Inc (RCKT) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 3.8%Here's What Happened - MarketBeat
Rocket Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
Rocket Pharmaceuticals Inc (RCKT) stock analysis: A comprehensive overview - US Post News
Ratio Review: Analyzing Rocket Pharmaceuticals Inc (RCKT)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
It makes sense and dollars to buy Rocket Pharmaceuticals Inc (RCKT) stock - SETE News
Rocket Pharmaceuticals Inc [NASDAQ: RCKT] Sees Decrease in Stock Value - Knox Daily
Dimensional Fund Advisors LP Trims Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 12-Month LowHere's What Happened - MarketBeat
Renaissance Technologies LLC Acquires Shares of 99,574 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
How the (RCKT) price action is used to our Advantage - Stock Traders Daily
A significant driver of top-line growth: Rocket Pharmaceuticals Inc (RCKT) - SETE News
Rocket Pharmaceuticals Inc: Navigating a Turbulent Year, Up -47.36% from 52-Week Low - The InvestChronicle
RCKT stock touches 52-week low at $16.51 amid market shifts - Investing.com
Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 7.4% - MarketBeat
Examining the Potential Price Growth of Rocket Pharmaceuticals Inc (RCKT) - Knox Daily
What is the investor’s view on Rocket Pharmaceuticals Inc (RCKT)? - US Post News
Rocket Pharmaceuticals' SWOT analysis: gene therapy stock faces market size concerns - Investing.com India
Metric Analysis: Rocket Pharmaceuticals Inc (RCKT)’s Key Ratios in the Limelight - The Dwinnex
Rocket Pharmaceuticals' (RCKT) "Buy" Rating Reiterated at Canaccord Genuity Group - MarketBeat
Novo Holdings A S Acquires 50,000 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals Inc [RCKT] Records 50-Day SMA of $20.33 - Knox Daily
Fanconi Anemia Market Expected to Experience Major Growth by 2034, According to DelveInsight | Novartis, Foresee Pharma, Rocket Pharma, Jasper Therapeutics - The Globe and Mail
Maverick Capital Ltd. Purchases 40,000 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Profund Advisors LLC Decreases Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 3.9% - Defense World
Rocket Pharmaceuticals Inc (RCKT) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Logos Global Management LP Has $7.54 Million Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 5.7% - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 5.7% - MarketBeat
Rocket Pharmaceuticals Inc (RCKT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Rocket Pharmaceuticals Inc 주식 (RCKT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Militello John | See Remarks |
Oct 31 '24 |
Sale |
16.62 |
917 |
15,245 |
50,534 |
2.02%
0.47%
자본화:
|
볼륨(24시간):